Uveal melanoma (UM) is the most common primary intraocular tumour in adults. The most accurate prognostic factor of UM is classification by gene expression profiling. Currently, the role of epigenetics is much less defined compared to genetic mechanisms. We recently showed a strong prognostic role of the expression levels of histone variant macroH2A1 in UM patients. Here, we assessed the mechanistic effects of macroH2A1 on UM progression.UM cell lines were stably knocked down (KD) for macroH2A1, and proliferation and colony formation capacity were evaluated. Mitochondrial function was assayed through qPCR and HPLC analyses. Correlation between mitochondrial gene expression and cancer aggressiveness was studied using a bioinformatics approach.MacroH2A1 loss significantly attenuated UM cells proliferation and aggressiveness. Furthermore, genes involved in oxidative phosphorylation displayed a decreased expression in KD cells. Consistently, macroH2A1 loss resulted also in a significant decrease of mitochondrial transcription factor A (TFAM) expression, suggesting impaired mitochondrial replication. Bioinformatics analyses uncovered that the expression of genes involved in mitochondrial metabolism correlates with macroH2A1 and with cancer aggressiveness in UM patients. Altogether, our results suggest that macroH2A1 controls UM cells progression and it may represent a molecular target to develop new pharmacological strategies for UM treatment.

Center for Translational Medicine St Anne's University Hospital Brno Czech Republic

Department G F Ingrassia Section of Anatomic Pathology University of Catania Catania Italy

Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Biomedical and Biotechnological Sciences University of Catania Catania Italy

Department of Ophthalmology University of Catania Catania Italy

EuroMediterranean Institute of Science and Technology Palermo Italy

UniCamillus Saint Camillus International University of Health Sciences Rome Italy

Zobrazit více v PubMed

Chang AE, Karnell LH, Menck HR. The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The american college of surgeons commission on cancer and the american cancer society. Cancer. 1998; 83:1664–78. 10.1002/(sici)1097-0142(19981015)83:8<1664::aid-cncr23>3.0.co;2-g PubMed DOI

Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003; 110:956–61. 10.1016/S0161-6420(03)00078-2 PubMed DOI

Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with Malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003; 44:4651–59. 10.1167/iovs.03-0538 PubMed DOI

Kath R, Hayungs J, Bornfeld N, Sauerwein W, Höffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993; 72:2219–23. 10.1002/1097-0142(19931001)72:7<2219::aid-cncr2820720725>3.0.co;2-j PubMed DOI

Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C. Focus on cutaneous and uveal melanoma specificities. Genes Dev. 2017; 31:724–43. 10.1101/gad.296962.117 PubMed DOI PMC

Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, et al.. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010; 363:2191–99. 10.1056/NEJMoa1000584 PubMed DOI PMC

Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010; 330:1410–13. 10.1126/science.1194472 PubMed DOI PMC

Scheuermann JC, de Ayala Alonso AG, Oktaba K, Ly-Hartig N, McGinty RK, Fraterman S, Wilm M, Muir TW, Müller J. Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB. Nature. 2010; 465:243–47. 10.1038/nature08966 PubMed DOI PMC

Machida YJ, Machida Y, Vashisht AA, Wohlschlegel JA, Dutta A. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem. 2009; 284:34179–88. 10.1074/jbc.M109.046755 PubMed DOI PMC

Masoomian B, Shields JA, Shields CL. Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma. J Curr Ophthalmol. 2018; 30:102–09. 10.1016/j.joco.2018.02.005 PubMed DOI PMC

Sarkar S, Goldgar S, Byler S, Rosenthal S, Heerboth S. Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy. Epigenomics. 2013; 5:87–94. 10.2217/epi.12.68 PubMed DOI

van der Velden PA, Metzelaar-Blok JA, Bergman W, Monique H, Hurks H, Frants RR, Gruis NA, Jager MJ. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma. Cancer Res. 2001; 61:5303–06. PubMed

Liu J, Ma L, Li C, Zhang Z, Yang G, Zhang W. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Mol Oncol. 2013; 7:1043–55. 10.1016/j.molonc.2013.08.003 PubMed DOI PMC

Sun L, Bian G, Meng Z, Dang G, Shi D, Mi S. MiR-144 inhibits uveal melanoma cell proliferation and invasion by regulating c-Met expression. PLoS One. 2015; 10:e0124428. 10.1371/journal.pone.0124428 PubMed DOI PMC

Xu H, Gong J, Liu H. High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma. PLoS One. 2017; 12:e0189675. 10.1371/journal.pone.0189675 PubMed DOI PMC

Li Y, Jia R, Ge S. Role of epigenetics in uveal melanoma. Int J Biol Sci. 2017; 13:426–33. 10.7150/ijbs.18331 PubMed DOI PMC

Bernstein E, Hake SB. The nucleosome: a little variation goes a long way. Biochem Cell Biol. 2006; 84:505–17. 10.1139/o06-085 PubMed DOI

Sarma K, Reinberg D. Histone variants meet their match. Nat Rev Mol Cell Biol. 2005; 6:139–49. 10.1038/nrm1567 PubMed DOI

Thambirajah AA, Li A, Ishibashi T, Ausió J. New developments in post-translational modifications and functions of histone H2A variants. Biochem Cell Biol. 2009; 87:7–17. 10.1139/O08-103 PubMed DOI

Giallongo S, Lo Re O, Vinciguerra M. Macro histone variants: emerging rheostats of gastrointestinal cancers. Cancers (Basel). 2019; 11:676. 10.3390/cancers11050676 PubMed DOI PMC

Lo Re O, Vinciguerra M. Histone MacroH2A1: a chromatin point of intersection between fasting, senescence and cellular regeneration. Genes (Basel). 2017; 8:367. 10.3390/genes8120367 PubMed DOI PMC

Buschbeck M, Hake SB. Variants of core histones and their roles in cell fate decisions, development and cancer. Nat Rev Mol Cell Biol. 2017; 18:299–314. 10.1038/nrm.2016.166 PubMed DOI

Costanzi C, Pehrson JR. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature. 1998; 393:599–601. 10.1038/31275 PubMed DOI

Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell. 2005; 8:19–30. 10.1016/j.devcel.2004.10.019 PubMed DOI

Changolkar LN, Costanzi C, Leu NA, Chen D, McLaughlin KJ, Pehrson JR. Developmental changes in histone macroH2A1-mediated gene regulation. Mol Cell Biol. 2007; 27:2758–64. 10.1128/MCB.02334-06 PubMed DOI PMC

Gamble MJ, Frizzell KM, Yang C, Krishnakumar R, Kraus WL. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev. 2010; 24:21–32. 10.1101/gad.1876110 PubMed DOI PMC

Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, Menendez S, Vardabasso C, Leroy G, Vidal CI, Polsky D, Osman I, Garcia BA, et al.. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature. 2010; 468:1105–09. 10.1038/nature09590 PubMed DOI PMC

Borghesan M, Fusilli C, Rappa F, Panebianco C, Rizzo G, Oben JA, Mazzoccoli G, Faulkes C, Pata I, Agodi A, Rezaee F, Minogue S, Warren A, et al.. DNA hypomethylation and histone variant macroH2A1 synergistically attenuate chemotherapy-induced senescence to promote hepatocellular carcinoma progression. Cancer Res. 2016; 76:594–606. 10.1158/0008-5472.CAN-15-1336 PubMed DOI PMC

Lo Re O, Fusilli C, Rappa F, Van Haele M, Douet J, Pindjakova J, Rocha SW, Pata I, Valčíková B, Uldrijan S, Yeung RS, Peixoto CA, Roskams T, et al.. Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma. Hepatology. 2018; 67:636–50. 10.1002/hep.29519 PubMed DOI

Park SJ, Shim JW, Park HS, Eum DY, Park MT, Mi Yi J, Choi SH, Kim SD, Son TG, Lu W, Kim ND, Yang K, Heo K. MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B. Oncogene. 2016; 35:1292–301. 10.1038/onc.2015.187 PubMed DOI PMC

Bereshchenko O, Lo Re O, Nikulenkov F, Flamini S, Kotaskova J, Mazza T, Le Pannérer MM, Buschbeck M, Giallongo C, Palumbo G, Li Volti G, Pazienza V, Cervinek L, et al.. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome. Clin Epigenetics. 2019; 11:121. 10.1186/s13148-019-0724-z PubMed DOI PMC

Salvatorelli L, Puzzo L, Bartoloni G, Palmucci S, Longo A, Russo A, Reibaldi M, Vinciguerra M, Li Volti G, Caltabiano R. Immunoexpression of Macroh2a in Uveal Melanoma. Applied Sciences. 2019; 9:3244 10.3390/app9163244 DOI

Lo Re O, Douet J, Buschbeck M, Fusilli C, Pazienza V, Panebianco C, Castracani CC, Mazza T, Li Volti G, Vinciguerra M. Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells. Epigenetics. 2018; 13:829–45. 10.1080/15592294.2018.1514239 PubMed DOI PMC

Kho D, MacDonald C, Johnson R, Unsworth CP, O’Carroll SJ, du Mez E, Angel CE, Graham ES. Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time. Biosensors (Basel). 2015; 5:199–222. 10.3390/bios5020199 PubMed DOI PMC

Lo Re O, Mazza T, Giallongo S, Sanna P, Rappa F, Vinh Luong T, Li Volti G, Drovakova A, Roskams T, Van Haele M, Tsochatzis E, Vinciguerra M. Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+ CD25+ FoxP3+ regulatory T cells activation. Theranostics. 2020; 10:910–24. 10.7150/thno.35045 PubMed DOI PMC

Posavec Marjanović M, Hurtado-Bagès S, Lassi M, Valero V, Malinverni R, Delage H, Navarro M, Corujo D, Guberovic I, Douet J, Gama-Perez P, Garcia-Roves PM, Ahel I, Ladurner AG, Yanes O, Bouvet P, Suelves M, Teperino R, Pospisilik JA, Buschbeck M. MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD(+) consumption. Nat Struct Mol Biol. 2017:24:902–10. 10.1038/nsmb.3481 PubMed DOI PMC

Cantó C, Menzies KJ, Auwerx J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015; 22:31–53. 10.1016/j.cmet.2015.05.023 PubMed DOI PMC

Stein LR, Imai S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab. 2012; 23:420–28. 10.1016/j.tem.2012.06.005 PubMed DOI PMC

Stiles AR, Simon MT, Stover A, Eftekharian S, Khanlou N, Wang HL, Magaki S, Lee H, Partynski K, Dorrani N, Chang R, Martinez-Agosto JA, Abdenur JE. Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion. Mol Genet Metab. 2016; 119:91–99. 10.1016/j.ymgme.2016.07.001 PubMed DOI

Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016; 1418:93–110. 10.1007/978-1-4939-3578-9_5 PubMed DOI PMC

Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016; 8:a019505. 10.1101/cshperspect.a019505 PubMed DOI PMC

Monteiro FL, Baptista T, Amado F, Vitorino R, Jerónimo C, Helguero LA. Expression and functionality of histone H2A variants in cancer. Oncotarget. 2014; 5:3428–43. 10.18632/oncotarget.2007 PubMed DOI PMC

van den Bosch T, Kilic E, Paridaens D, de Klein A. Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract. 2010; 2010:360136. 10.1155/2010/360136 PubMed DOI PMC

Grossniklaus HE. Understanding uveal melanoma metastasis to the liver: the zimmerman effect and the zimmerman hypothesis. Ophthalmology. 2019; 126:483–87. 10.1016/j.ophtha.2018.09.031 PubMed DOI

van der Kooij MK, Speetjens FM, van der Burg SH, Kapiteijn E. Uveal versus cutaneous melanoma; same origin, very distinct tumor types. Cancers (Basel). 2019; 11:845. 10.3390/cancers11060845 PubMed DOI PMC

Heijkants R, Willekens K, Schoonderwoerd M, Teunisse A, Nieveen M, Radaelli E, Hawinkels L, Marine JC, Jochemsen A. Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma. Oncotarget. 2017; 9:6174–87. 10.18632/oncotarget.23485 PubMed DOI PMC

van Ginkel PR, Darjatmoko SR, Sareen D, Subramanian L, Bhattacharya S, Lindstrom MJ, Albert DM, Polans AS. Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Invest Ophthalmol Vis Sci. 2008; 49:1299–306. 10.1167/iovs.07-1233 PubMed DOI PMC

Lu C, Song E, Hu DN, Chen M, Xue C, Rosen R, McCormick SA. Curcumin induces cell death in human uveal melanoma cells through mitochondrial pathway. Curr Eye Res. 2010; 35:352–60. 10.3109/02713680903521944 PubMed DOI

Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SP. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016; 122:2299–312. 10.1002/cncr.29727 PubMed DOI PMC

Ewens KG, Kanetsky PA, Richards-Yutz J, Purrazzella J, Shields CL, Ganguly T, Ganguly A. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. Invest Ophthalmol Vis Sci. 2014; 55:5160–67. 10.1167/iovs.14-14550 PubMed DOI

Chattopadhyay C, Oba J, Roszik J, Marszalek JR, Chen K, Qi Y, Eterovic K, Robertson AG, Burks JK, McCannel TA, Grimm EA, Woodman SE. Elevated endogenous SDHA drives pathological metabolism in highly metastatic uveal melanoma. Invest Ophthalmol Vis Sci. 2019; 60:4187–95. 10.1167/iovs.19-28082 PubMed DOI PMC

Oliva CR, Markert T, Gillespie GY, Griguer CE. Nuclear-encoded cytochrome C oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas. Oncotarget. 2015; 6:4330–44. 10.18632/oncotarget.3015 PubMed DOI PMC

Wilson AA, Kwok LW, Porter EL, Payne JG, McElroy GS, Ohle SJ, Greenhill SR, Blahna MT, Yamamoto K, Jean JC, Mizgerd JP, Kotton DN. Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages. Mol Ther. 2013; 21:825–33. 10.1038/mt.2013.19 PubMed DOI PMC

Benegiamo G, Vinciguerra M, Mazzoccoli G, Piepoli A, Andriulli A, Pazienza V. DNA methyltransferases 1 and 3b expression in huh-7 cells expressing HCV core protein of different genotypes. Dig Dis Sci. 2012; 57:1598–603. 10.1007/s10620-012-2160-1 PubMed DOI

Sheedfar F, Sung MM, Aparicio-Vergara M, Kloosterhuis NJ, Miquilena-Colina ME, Vargas-Castrillón J, Febbraio M, Jacobs RL, de Bruin A, Vinciguerra M, García-Monzón C, Hofker MH, Dyck JR, Koonen DP. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. Aging (Albany NY). 2014; 6:281–95. 10.18632/aging.100652 PubMed DOI PMC

Sigala B, McKee C, Soeda J, Pazienza V, Morgan M, Lin CI, Selden C, Vander Borght S, Mazzoccoli G, Roskams T, Vinciguerra M, Oben JA. Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells. PLoS One. 2013; 8:e72928. 10.1371/journal.pone.0072928 PubMed DOI PMC

Pazienza V, Borghesan M, Mazza T, Sheedfar F, Panebianco C, Williams R, Mazzoccoli G, Andriulli A, Nakanishi T, Vinciguerra M. SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation. Aging (Albany NY). 2014; 6:35–47. 10.18632/aging.100632 PubMed DOI PMC

Lazzarino G, Amorini AM, Fazzina G, Vagnozzi R, Signoretti S, Donzelli S, Di Stasio E, Giardina B, Tavazzi B. Single-sample preparation for simultaneous cellular redox and energy state determination. Anal Biochem. 2003; 322:51–59. 10.1016/j.ab.2003.07.013 PubMed DOI

Romitelli F, Santini SA, Chierici E, Pitocco D, Tavazzi B, Amorini AM, Lazzarino G, Di Stasio E. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the griess assay. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 851:257–67. 10.1016/j.jchromb.2007.02.003 PubMed DOI

Laurent C, Valet F, Planque N, Silveri L, Maacha S, Anezo O, Hupe P, Plancher C, Reyes C, Albaud B, Rapinat A, Gentien D, Couturier J, et al.. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res. 2011; 71:666–74. 10.1158/0008-5472.CAN-10-0605 PubMed DOI

Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Truini M, Angelini G, Boccardo S, Cilli M, et al.. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One. 2012; 7:e29989. 10.1371/journal.pone.0029989 PubMed DOI PMC

van Essen TH, van Pelt SI, Bronkhorst IH, Versluis M, Némati F, Laurent C, Luyten GP, van Hall T, van den Elsen PJ, van der Velden PA, Decaudin D, Jager MJ. Upregulation of HLA expression in primary uveal melanoma by infiltrating leukocytes. PLoS One. 2016; 11:e0164292. 10.1371/journal.pone.0164292 PubMed DOI PMC

Amaro A, Mirisola V, Angelini G, Musso A, Tosetti F, Esposito AI, Perri P, Lanza F, Nasciuti F, Mosci C, Puzone R, Salvi S, Truini M, et al.. Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by gefitinib and cetuximab triggered antibody-dependent cellular cytotoxicity. Eur J Cancer. 2013; 49:3353–65. 10.1016/j.ejca.2013.06.011 PubMed DOI

Field MG, Decatur CL, Kurtenbach S, Gezgin G, van der Velden PA, Jager MJ, Kozak KN, Harbour JW. PRAME as an independent biomarker for metastasis in uveal melanoma. Clin Cancer Res. 2016; 22:1234–42. 10.1158/1078-0432.CCR-15-2071 PubMed DOI PMC

Newman AM, Gallo NB, Hancox LS, Miller NJ, Radeke CM, Maloney MA, Cooper JB, Hageman GS, Anderson DH, Johnson LV, Radeke MJ. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 2012; 4:16. 10.1186/gm315 PubMed DOI PMC

Xiao J, Cao H, Chen J. False discovery rate control incorporating phylogenetic tree increases detection power in microbiome-wide multiple testing. Bioinformatics. 2017; 33:2873–81. 10.1093/bioinformatics/btx311 PubMed DOI

Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3:Article3. 10.2202/1544-6115.1027 PubMed DOI

Davis S, Meltzer PS. GEOquery: A bridge between the gene expression omnibus (GEO) and BioConductor. Bioinformatics. 2007; 23:1846–47. 10.1093/bioinformatics/btm254 PubMed DOI